Itau Unibanco Holding S.A. Verve Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.76 - $12.79 $13,908 - $37,372
2,922 New
2,922 $14,000
Q4 2023

Feb 14, 2024
BUY
$8.84 - $18.7 $2,855 - $6,040
323 Added 20.77%
1,878 $26,000
Q3 2023

Nov 14, 2023
BUY
$11.42 - $20.82 $4,373 - $7,974
383 Added 32.68%
1,555 $20,000
Q2 2023

Aug 14, 2023
BUY
$13.34 - $19.9 $15,634 - $23,322
1,172 New
1,172 $21,000

Others Institutions Holding VERV

# of Institutions
186
Shares Held
73.3M
Call Options Held
85K
Put Options Held
215K
View Full List

About Verve Therapeutics, Inc.

VERV Quotes by TradingView
  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $291M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email